| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |